Novel issues in the epidemiology of asbestos-related diseases

Abstract

Purpose of review Exposure to asbestos continues to persist because of the use of this mineral in developing countries and because of the naturally occurring asbestos and of the presence of asbestos in the asbestos-containing materials. After more than 30 years since the ban in some countries, asbestos-related malignancies are still diagnosed yearly. Thus, we conducted a systematic search for articles regarding epidemiologic advances in asbestos-related diseases in the last 18 months in order to summarize the newest findings that could, eventually, improve the prevention strategies for asbestos-related cancers. Recent findings There are advances regarding the diagnosis and treatment of mesothelioma. Recent publications confirm a trend for mesothelioma for time since last exposure, while for asbestos-related lung cancer, findings show a linear association between asbestos exposure level and lung cancer risk. Other asbestos-related malignancies have been hypothesized. The importance of an accurate diagnosis of mesothelioma has been further emphasized for the prognosis and therapeutic success of this cancer. Summary Latest findings allow public health to project prevention, and clinicians to project better treatment strategies for asbestos-related diseases. More studies on the treatment options are needed and ‘Tailored’ therapy should be among the focal points.